Australia cracks down on unproven stem cell therapies
As in the US, unproven stem cell therapies have been marketed in Australia.Therapeutic Goods Administration (TGA, similar to US FDA) of the Australian Government tightened regulations around advertising autologous (self) human cell and tissue products.
As of July 1, 2018, these products cannot be marketed to consumers, and adverse events must be reported to the TGA.
Information Notice:
The information on this page is intended for scientific, educational, and general informational purposes. Clinical approaches, availability, and regulatory status may vary by country, institution, and medical indication. For individual medical decisions, readers should consult qualified healthcare professionals and accredited medical centers.
The information on this page is intended for scientific, educational, and general informational purposes. Clinical approaches, availability, and regulatory status may vary by country, institution, and medical indication. For individual medical decisions, readers should consult qualified healthcare professionals and accredited medical centers.
Editorial Note:
This article has been prepared by the NBScience editorial team within the scope of clinical research, biotechnology, and international medical information.
This article has been prepared by the NBScience editorial team within the scope of clinical research, biotechnology, and international medical information.
